Literature DB >> 35711139

Snail Promotes Cancer Cell Proliferation via Its Interaction with the BIRC3.

Seung Bae Rho1, Hyun-Jung Byun2, Boh-Ram Kim2, Chang Hoon Lee2.   

Abstract

Snail is implicated in tumour growth and metastasis and is up-regulated in various human tumours. Although the role of Snails in epithelial-mesenchymal transition, which is particularly important in cancer metastasis, is well known, how they regulate tumour growth is poorly described. In this study, the possible molecular mechanisms of Snail in tumour growth were explored. Baculoviral inhibitor of apoptosis protein (IAP) repeat-containing protein 3 (BIRC3), a co-activator of cell proliferation during tumourigenesis, was identified as a Snail-binding protein via a yeast two-hybrid system. Since BIRC3 is important for cell survival, the effect of BIRC3 binding partner Snail on cell survival was investigated in ovarian cancer cell lines. Results revealed that Bax expression was activated, while the expression levels of anti-apoptotic proteins were markedly decreased by small interfering RNA (siRNA) specific for Snail (siSnail). siSnail, the binding partner of siBIRC3, activated the tumour suppressor function of p53 by promoting p53 protein stability. Conversely, BIRC3 could interact with Snail, for this reason, the possibility of BIRC3 involvement in EMT was investigated. BIRC3 overexpression resulted in a decreased expression of the epithelial marker and an increased expression of the mesenchymal markers. siSnail or siBIRC3 reduced the mRNA levels of matrix metalloproteinase (MMP)-2 and MMP-9. These results provide evidence that Snail promotes cell proliferation by interacting with BIRC3 and that BIRC3 might be involved in EMT via binding to Snail in ovarian cancer cells. Therefore, our results suggested the novel relevance of BIRC3, the binding partner of Snail, in ovarian cancer development.

Entities:  

Keywords:  BIRC3; Ovarian cancer; P53; Proliferation; Snail; Yeast two-hybrid

Year:  2022        PMID: 35711139      PMCID: PMC9252879          DOI: 10.4062/biomolther.2022.063

Source DB:  PubMed          Journal:  Biomol Ther (Seoul)        ISSN: 1976-9148            Impact factor:   4.231


INTRODUCTION

Ovarian tumours are the leading cause of gynecologic cancer deaths in Western countries. Their risk factors include fertility, obesity, hormone replacement therapy after menopause, and smoking (Clarfield ). In 2020, ovarian cancer was diagnosed in 239,000 females and resulted in 207,252 deaths (Elshami ). Epithelial-mesenchymal transition (EMT) is a pivotal mechanism in the initial steps of ovarian cancer metastasis and invasion (Lee, 2018, 2019; Cai ). Kurrey reported that over-expression of Snail or Slug results in EMT, which promoted cell motility, invasiveness and tumorigenicity in SKOV3 cells. Yuan also reported that ALX1, the homeobox transcription factor ALX1 provokes Snail expression to promote EMT of ovarian cancer cells. In addition, Blechschmidt demonstrated that Snail, an E-cadherin repressor, is related to the reduced overall survival of patients with ovarian tumours. Snail also plays an important role in ovarian tumour growth and metastasis via the regulation of MMP activity (Jin ). Snail is a transcription factor that participates in EMT (Nam ). The Snail family of zinc-finger transcription factors includes Snail1 (Snail), Snail2 (Slug), and Snail3 (Smuc) in vertebrates (Debnath ). Snail1 (Snail) and Snail2 (Slug) are necessary to trigger EMT during embryonic development and cancer progression (Nieto, 2002; Peiro ; Wu and Zhou, 2010; Debnath ). The C-terminal region of Snail1 binds to DNA and the N-terminal region represses transcription (Peinado ). In the central domain, a serine-rich sequence (SRS) and a nuclear export sequence (NES) control Snail subcellular localization and protein stability, respectively (Domínguez ). Although the biological functions of Snail in malignancies have been characterized extensively, its molecular mechanisms are unclear. In this study, we used a yeast two-hybrid system to screen a human cDNA library for novel Snail-interacting proteins and characterize the biological functions of snails in ovarian cancer. We also reported novel insights into the roles of the Snails and its new binding partner in modulating cancer cell proliferation.

MATERIALS AND METHODS

Cell lines, culture, and antibodies

Human carcinoma cell lines (SKOV-3, HeLa, HCT116) were obtained from the American Type Culture Collection (ATCC, Rockville, MD, USA). Cells were seeded in Roswell Park Memorial Institute (RPMI) 1640 medium, supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin (100 units/mL and 100 µg/mL, respectively) in 5% CO2 at 37°C. Other chemicals were obtained from Sigma (St. Louis, MO, USA). The following primary antibodies were used in this study: anti-Snail, anti-BIRC3, anti-Bax, anti-Bcl-xL, anti-Mcl-1, anti-Bcl-2, anti-p53, anti-α-tubulin, N-cadherin, anti-activated Ras-related C3 botulinum toxin substrate 1 (Rac1), anti-Rac1 (Cell Signaling, Beverly, MA, USA), anti-green fluorescent protein (GFP), anti-p53 up-regulated modulator of apoptosis (PUMA), anti-E-cadherin, anti-β-catenin, anti-vimentin, anti-fibronectin, anti-activated-Rho, anti-Rho, anti-activated cell division control protein 42 homolog (Cdc42), anti-Cdc42, and anti-β-actin (Sigma).

Cell viability analysis

Cell viability was evaluated using 3-(4,5-dimethylthiazol-2-yl)-2.5-diphenyl-2H-tetrazolium bromide (MTT) assays (Rho ). Cells were grown at a density of 4.3×103 per well in 96-well plates. Three days after transfection, a fresh medium including 10% FBS and 20-µL MTT solution (5 µg/mL; Sigma) were added to each well, followed by incubation for an additional 4 h at 37°C. After centrifugation at 500 g for 10 min, the supernatant was decanted and the formazan was dissolved with dimethyl sulfoxide (DMSO). The amounts of MTT-formazan generated were determined by measuring the absorbance at 540 nm using a microplate reader.

RNA isolation and reverse transcription-polymerase chain reaction (RT-PCR)

Total RNA was isolated from cells using TRIzol® (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocols (Kim ). Total RNA (1 µg) was reverse transcribed to cDNA using a First-Strand cDNA Synthesis Kit with oligo-dT primers (SuperScript™ RT, Invitrogen). To detect human Snail, BIRC3, MMP-2, MMP-9, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), mRNA transcripts were isolated by PCR as described above. The primers were as follows: Snail, 5’-TTC TTC GCT ACT GCT GCG-3’ (forward) and 5’-GGG CAG GTA TGG AGA GGA AGA-3’ (reverse); BIRC3, 5’-AGG TGT TGG GAA TCT GGA GAT-3’ (forward) and 5’- GCA GCA TTA ATC ACA GGA GTA-3’ (reverse); MMP-2, 5’-ATG GGG AAT CGG TTG AAG G-3’ (forward) and 5’-AAT TGC ATT TCC TGA CAG AAG G-3’ (reverse); MMP-9, 5’-ACG CAG ACA TCG TCA TCC AGT-3’ (forward) and 5’-GGA CCA CAA CTC GTC ATC GTC-3’ (reverse); and GAPDH, 5’-GAG TCA ACG GAT TTG GTC GTA-3’ (forward) and 5’-CTT CTC CAT GGT TGG TGA AGA-3’ (reverse). The specificity of the amplified PCR fragments was confirmed by sequencing.

Silencing of gene expression by small interfering RNA (siRNA)

Oligonucleotides including an RNA interference (RNAi) sequence [Snail: 5’- GCC UUC AAC UGC AAA UAC U-3’ (sense) and 5’-AGU AUU UGC AGU UGA AGG C-3’ (antisense); BIRC3, 5’-UAA GGG AAG AGG AGA GAG AA-3’ (sense) and 5’-UUC UCU CUC CUC UUC CCU UA-3’ (antisense)] were synthesized using an RNAi construction kit (Ambion, Austin, TX, USA), and were then transfected with Lipofectamine® 2000 reagent (Invitrogen) according to the manufacturer’s protocols (Rho ). The following unrelated non-specific scrambled oligonucleotide was used as a control: [Snail, 5’-TAT TGC CTA GCA TTA CGT T-3’ (sense) and 5’-GTA TTG CCT AGC ATT ACG T-3’ (antisense); BIRC3, 5’-CCT GGT AGC AGC GAG TGA G-3’ (sense) and 5’-CTC ACT CGC TGC TAC CAG G-3’ (antisense)]. Cells grown for 24 h were transfected with 150 nM siSnail or siBIRC3. At 24 h after transfection, cells were prepared for MTT assay and immunoblotting analysis.

Western blot analysis

Western blot assay was performed as previously described (Yu ). Cells were collected, rinsed twice with cold phosphate-buffered saline (PBS), centrifuged, and lysed in cold lysis buffer containing a protease inhibitor cocktail (Sigma) at 4°C for 50 min. The cell lysates were subsequently separated with 8%-12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto Hybond enhanced chemiluminescence (ECL) nitrocellulose membrane (GE Healthcare, Little Chalfont, Buckinghamshire, UK). After blocking, the membranes were incubated with primary antibodies at 4°C overnight. The membranes were rinsed thrice with Tris-buffered saline and Tween 20 (TBST) wash buffer and incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (Cell Signaling). Immunoreactive bands were developed using an ECL detection system (GE Healthcare).

Yeast two-hybrid assay system

The full-length cDNA of the human Snail gene was subcloned into the EcoRI and XhoI restriction enzyme sites of the pGilda vector. A full-length human BIRC3 cDNA was introduced into a pJG4-5 activation vector at the EcoRI and XhoI sites to generate B42 fusion proteins. Positive interactions were indicated by the formation of blue colonies on an X-gal-containing medium, as described previously (Kim ). Interaction binding activity was compared by calculating the relative expression level of o-nitrophenyl β-D-galactopyranoside (ONPG) β-galactosidase (Rho ; Dong ).

Promoter-reporter gene analysis

In vitro promoter luciferase activity was assayed as described previously (Rho ). In brief, cells were transfected with vector DNA containing Bcl-2-, p21-, or p53-luciferase, in which luciferase is expressed under the control of the respective promoters. After reaching 85% confluency, cells were transfected with the indicated reporter constructs. As an internal control to correct for variations in transfection efficiency, 20 ng of pRL-TK (Promega, Madison, WI, USA) were co-transfected. The transfections were accomplished using Oligofectamine™ (Invitrogen). After lysis with Reporter Lysis Buffer (Promega), the cell extracts were incubated with the luciferase substrate at room temperature for 30 min. Then, a 5-µL aliquot of each sample was transferred into a MicroLumat Plus LB96 V luminometer (Berthold Technologies, Bad Wildbad, Germany). Reporter activity was measured using a Dual-Luciferase® Reporter (DLR™) Assay System (Promega) according to the manufacturer’s directions, and reporter activity was normalized to that of Renilla luciferase to correct for variations in the transfection efficiency.

Statistical analysis

Results are presented as means ± standard deviation (SD) of four independent experiments. Student’s t-test was used for comparisons between the two groups. Statistically significant differences (p<0.05) are indicated by asterisks (*).

RESULTS

Snail directly binds with BIRC3

A yeast two-hybrid method was used to determine whether BIRC3 is a binding partner of Snail. In Fig. 1A, a positive binding activity was identified in the Snail/BIRC3-binding assay system (76.17 ± 0.72), whereas a low β-galactosidase binding activity was detected in the Snail/empty vector expression system (1.47 ± 0.42). Then, Snail and BIRC3 were co-immunoprecipitated (Co-IP) to confirm the direct interaction between Snail and BIRC3 observed in cells. The cDNA constructs of BIRC3 (pcDNA3.1/Flag-BIRC3) and Snail (pcDNA3.1-Snail), or pcDNA3.1/Flag-BIRC3 and empty vector only (pcDNA3.1), were co-transfected into cells. Snail precipitated with BIRC3, whereas Co-IP failed to detect any protein-protein interaction between pcDNA3.1 (empty vector-only) or pcDNA3.1 with Flag-BIRC3 (Fig. 1B). Subsequently, the cellular interactions of the two proteins were validated by the Co-IP of endogenous Snail and BIRC3. Subsequently, endogenously expressed Snail protein directly co-immunoprecipitated with BIRC3 (Fig. 1C).
Fig. 1

Physical interaction between Snail and the Baculoviral inhibitor of apoptosis protein (IAP) repeat-containing protein 3 (BIRC3). (A) Positive interactions were observed by monitoring cell growth over 3 days at 30°C on a medium lacking leucine. The values of β-galactosidase activity (unit) calculated by adding O-nitrophenyl β-D-galactopyranoside (ONPG) are indicated below the corresponding lanes. (B) Co-immunoprecipitation (Co-IP) of Snail with BIRC3. Immunoprecipitation was carried out using an anti-Flag antibody with lysates from transfected breast carcinoma cells. After immunoprecipitation, precipitated proteins were immunoblotted with anti-Snail and anti-BIRC3 antibodies: lane 1, pcDNA3.1 (vector only) and pcDNA3.1/Flag-BIRC3 transfectant; lane 2, pcDNA3.1-Snail and pcDNA3.1/Flag-BIRC3 transfectant. (C) Co-IP of endogenous BIRC3 and Snail shows the interaction between the two proteins in HEK 293T cells. β-actin was used as a loading control.

siSnail and siBIRC3 induce apoptotic death of carcinoma cells

The effect of Snail and BIRC3 on ovarian tumour cell proliferation was examined. Snail and BIRC3 were highly expressed at mRNA and protein levels. Snail expression was inhibited dramatically after Snail siRNA transfection (Fig. 2A), and cellular proliferation was reduced significantly (Fig. 2B). BIRC3 overexpression promoted cell growth, whereas cell growth was suppressed by BIRC3 siRNA. The proliferation of cells transfected with siSnail were inhibited to ~40% compared with that of the cells transfected with the control (expression vector only). siBIRC3 transfection reduced cell viability by 42%, and the transfection of siSnail plus siBIRC3 additively inhibited cellular viability. Therefore, Snail directly interacts with BIRC3 under biological cellular conditions (Fig. 2B).
Fig. 2

Effects of snail siRNA and BIRC3 siRNA on the proliferation of cancer cells and effects of BIRC3 siRNA on snail expression. (A) Reverse transcription-polymerase chain reaction (RT-PCR) showing decreased Snail and BIRC3 mRNA levels following transfection with plasmid constructs targeting Snail and BIRC3. Representative Western blot of Snail and BIRC3 proteins in control (siScramble) and siSnail and siBIRC3. Quantification of RT-PCR and Western blot data (right panel). Results represent the means ± SD of at least three independent experiments performed in triplicate. *p<0.05 compared to the siScramble control group. (B) Cells were transfected with control, Snail, Snail plus siSnail, BIRC3, BIRC3 plus siBIRC3, Snail plus BIRC3, and siSnail plus siBIRC3 plasmid, respectively. Relative cell proliferation rates were calculated by MTT assay. MTT-formazan amounts were calculated by measuring the absorbance at 540 nm in a microplate reader, and absorbance values were converted to relative proliferation rates. Each data point represents triplicate samples, and the bars indicate the means ± standard deviation (SD). *p<0.05. (C) Cells were transfected with various concentrations of siBIRC3 or siSnail, and then total cell lysates were prepared. Snail and BIRC3 proteins in cells were visualized using immunoblotting. (D) Protein levels of B-cell lymphoma (Bcl-2) family genes were analyzed by immunoblot analysis of the SKOV-3 cells transfected with siSnail and siSnail plus Snail or siBIRC3 and siBIRC3 plus BIRC3. β-actin was used as a loading control and was immunoblotted with antibodies to Snail, BIRC3, Bax, Bcl-xL, Mcl-1, and Bcl-2. (E) Promoter activities of Bcl-2 were measured through a luciferase reporter gene assay system with Bcl-2 (Bcl-2-Luc) promoter reporters, respectively. For instance, the Bcl-2-luciferase reporter gene constructs or promoter-less plasmid vectors only were transiently transfected into SKOV-3 cells. Cells were incubated for 24 h and then resuspended in lysis buffer. After collection by centrifugation, cells were lysed, mixed with the luciferase reaction substrate, and then assayed for luciferase activity. Results represent the means ± SD of at least three independent experiments performed in triplicate. *p<0.05. The experiments were repeated three times with similar results. IP, immunoprecipitation; WB, Western blot; WCL, whole-cell lysates.

To explore the biological function of siBIRC3 during Snail-induced cell proliferation, we investigated Snail protein expression through transient siBIRC3 transfection. As presented in Fig. 2C, siBIRC3 transfection reduced Snail protein levels in a concentration-dependent manner (upper panel). In the case of siSnail transfection, BIRC3 protein level patterns were similar to those of the Snail protein (lower panel). Subsequently, we assessed Snail- and BIRC3-induced cell proliferation by determining the activation levels of apoptosis-associated proteins, such as Bax, B-cell lymphoma-extra large (Bcl-xL), myeloid cell leukaemia 1 (Mcl-1), and B-cell lymphoma 2 (Bcl-2), which are well-known pivotal modulators of cell death and proliferation. Fig. 2D shows that the Bax expression in the transfections was reduced compared with that in the CTR (control), whereas Bcl-xL, Mcl-1, and Bcl-2 were activated by Snail and BIRC3. We transfected the cells with specific RNAi (siSnail and siBIRC3) to verify these results. Bax expression was activated, while the expression levels of Bcl-xL, Mcl-1, and Bcl-2 were decreased markedly by siSnail and siBIRC3. To assess the biological effects of siSnail on Snail-stimulated proliferation, we transfected the cells with siSnail and Snail, or with siBIRC3 and BIRC3 expression plasmids. We then measured the promoter activity by using a dual-luciferase reporter gene assay system. Fig. 2E illustrates that the Bcl-2 activity was noticeably reduced by siSnail and siBIRC3. Therefore, Snail and BIRC3 knockdown effectively inhibited the established tumour growth in vitro by inducing apoptosis.

Effects of Snail and BIRC3 knockdown by siRNA on p53

We additional conformed that p53 promoter activity was inhibited by siSnail and siBIRC3 by dual-luciferase reporter gene assay (Fig. 3A). To better understand the effects of Snail and BIRC3 on p53, cells were transfected with siSnail and Snail or with siBIRC3 and BIRC3 for increasing periods after cycloheximide (CHX) treatment. Interestingly, endogenous p53 levels were significantly reduced by CHX treatment in a time-dependent manner (Fig. 3B, left panel). Conversely, Snail and BIRC3 knockdown stabilized the p53 protein level (Fig. 3B, right panel). These results suggested that siSnail and siBIRC3 activated the p53 tumour-suppressor function by promoting p53 protein stability. A Flag-tagged Snail and BIRC3 plasmid were introduced into HCT116 p53+/+ and p53–/– cells to assess whether the increase in PUMA was attributed to the direct regulation of p53 by Snail and BIRC3. PUMA expression was reduced in p53+/+ cells but not in p53–/– cells (Fig. 3C), indicating that PUMA regulation by Snail and BIRC3 was dependent on p53.
Fig. 3

Snail and BIRC3 reduce the promoter activity of p53 and decrease the half-life of the p53 protein. (A) Promoter activities of p53 were measured through a luciferase reporter gene assay system with a p53 (p53-Luc) promoter-reporter. For instance, the p53 luciferase reporter gene constructs or promoter-less plasmid vectors only were transiently transfected into SKOV-3 cells. Cells were incubated for 24 h and then resuspended in lysis buffer. After collection by centrifugation, cells were lysed, mixed with the luciferase reaction substrate, and then assayed for luciferase activity. Results represent the means ± SD of at least three independent experiments performed in triplicate. *p<0.05. (B) p53 protein stability was evaluated in HeLa cells transfected with siScramble (control), siSnail, or siBIRC3. Twenty-four hours after transfection, cells were treated with cycloheximide (50 mg/mL) for the indicated periods. Cell lysates were developed by immunoblotting with an anti-p53 antibody. α-tubulin served as a loading control. (C) One microgram of Flag-Snail and Flag-control (plasmid vector-only) or Flag-BIRC3 and Flag-control was transfected into p53+/+ or p53–/– HCT116 cells. At 48 h post-transfection, cell lysates were visualized by immunoblotting with the indicated specific antibodies.

Involvement of BIRC3 in the EMT

Since Snail is a transcription factor involved in EMT, the possibility of the EMT involvement of BIRC3 binding to Snail was investigated. E-cadherin expression was decreased when BIRC3 was overexpressed (Fig. 4A, right panel). This reduction was similar to that when Snail was overexpressed (Fig. 4A, left panel). Conversely, the expression of mesenchymal proteins, particularly N-cadherin, vimentin, and fibronectin, was significantly increased in Snail- and BIRC3-expressing cells compared with that in control-expressing cells (Fig. 4A). Conversely, when gene silencing was performed with siBRC3, the E-cadherin expression was restored, and the N-cadherin and vimentin expression levels were decreased (Fig. 4A, right panel). This recovery was similar to that of Snail gene silencing (Fig. 4A, left panel).
Fig. 4

Changes in epithelial–mesenchymal transition (EMT) markers, regulatory factors and MMP2 and MMP9 following ovarian tumor cell transfection with Snail and BIRC3. (A) Expression of epithelial markers (E-cadherin and β-catenin) and mesenchymal markers (N-cadherin, vimentin, and fibronectin) in tumour cells with or without Snail and BIRC3 transfection were investigated by immunoblotting. β-actin was used as a loading control. (B) Snail and BIRC3 mRNA expression following transfection with various concentrations of siSnail and siBIRC3, respectively (upper panel). MMP-2 and MMP-9 mRNA expression was evaluated using RT-PCR (lower panel).

MMPs play a pivotal role in invasion (Nagase and Woessner, 1999) and are frequently up-regulated in EMT (Scheau ). SKOV-3 cells were transfected with siSnail or siBIRC3 to demonstrate the effect of the siRNA-mediated down-regulation of Snail and BIRC3 on MMP-2 and MMP-9, and target gene expression was evaluated through RT-PCR and Western blot. As shown in Fig. 4B, the knockdown of Snail or BIRC3 by siRNA markedly reduced the mRNA levels of MMP-2 and MMP-9 (Fig. 4B).

DISCUSSION

EMT plays a critical role in ovarian tumour progression, including enhancing cell migration and invasive ability (Vergara ; Lili ; Lambert and Weinberg, 2021). The relationship between Snail and BIRC3 in cellular biological function was previously unknown. Thus, in the present study, we revealed that the BIRC3 protein, an inhibitor of apoptotic proteins, was a novel Snail-binding protein. In this study, the yeast two-hybrid method revealed that Snail interacted with BIRC3 (Fig. 1). BIRC3 is an IAP family member that suppresses apoptotic cell death by interfering with caspase activation (Frazzi, 2021). In tumours, BIRC3 is often up-regulated in various cancers, including cervical cancer (Imoto ; Wu ), hepatocellular carcinoma (Zender ; Jiang ), non-small and small cell lung cancer (Ferreira ; Dai ; Liu ), oesophageal squamous cell cancer (Imoto ; Wu ), oral squamous cell carcinoma (Snijders ; Bi ), and pancreatic cancer (Esposito ; Yu ). BIRC3 interacts with molecules other than Snail. For example, BIRC3 interacts with various intracellular proteins, such as receptor-interacting protein 1 (RIP1) (Bertrand ), tumour necrosis factor receptor-associated factor 1 (TRAF1) (Li ), TRAF2 (Yoneda ; Zheng ), and ubiquitin-conjugating enzyme E2 D2 (UBE2D2) (Mace ). Snail binds to various intracellular proteins, including the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex (Peinado ), polycomb repressive complex 2 (PRC2) (Herranz ), 14-3-3 and protein arginine methyltransferase 5 (PRMT5)/AJUBA complex (Hou , 2010), lysine-specific demethylase 1 (LSD1) (Lin ), and small C-terminal domain phosphatase (SCP) (Wu ). This binding causes the inhibition of Snail dephosphorylation and stabilization following the loss of the Snail C-terminal domain (Wu ). Dong reported that Snail interacts with the suppressor of variegation 3-9 homolog 1 (Suv39H1) in vivo, and its expression is correlated with breast cancer metastasis. Therefore, BIRC3 is also a new member that combines with Snail. Interestingly, the decrease in the BIRC3 expression induced a decrease in the Snail expression, and the decrease in the Snail expression inversely caused the decrease in the BIRC3 expression (Fig. 2C). However, studies have yet to clarify how such a relationship can be established. BIRC3 affects cell viability, as mentioned earlier (Frazzi, 2021). In the present study, the effect of the interaction of Snail with BIRC3 on the survival of ovarian cancer cell lines was investigated, and the results indicated that siSnail treatment significantly reduced cell survival. The simultaneous siBIRC3 treatment further increased this reduced survival (Fig. 2B). The treatment with siSnail also induced a decrease in the expression of cell survival-related molecules, such as Bax, Bcl-XL, Mcl-1 and Bcl-2, and Snail re-expression reversed this observation and restored the expression of these cell survival molecules (Fig. 2D, left panel). Likewise, the treatment with siBIRC3 resulted in a decrease in cell survival-related molecules similar to siSnail, and BIRC3 re-expression similarly reversed this result (Fig. 2D, right panel). In our investigation into how BIRC3 and Snail expressed Bcl-2, treatment with siBIRC3 and siSnail induced a decrease in the Bcl-2 luciferase activity. Thus, siBIRC3 and siSnail appear to inhibit the Bcl-2 expression at the transcriptional level (Fig. 2E). Studies have yet to determine how snail and BIRC3 regulate the Bcl-2 expression at the transcriptional level. However, MnSOD overexpression confers cisplatin resistance in lung adenocarcinoma via the NF-κB/Snail/Bcl-2 pathway (Chen ). Therefore, Snail is a member of an NF-κB/Snail/Bcl-2 axis that increases Bcl-2 expression. Herbert demonstrated that mammary epithelial cells harbouring the TP53 M133T mutation displayed a significant increase (20-40 fold) in the expression of the anti-apoptotic gene BIRC3. These results suggested an association between p53 and BIRC3. The siBIRC3 expression increased the p53 expression, similarly, the knockdown of Snail, a binding partner of BIRC3, increased the p53 expression (Fig. 3A). Snail and p53 were inversely correlated, and BIRC3 was likely involved in this relationship. Snail and BIRC3 possibly affected p53 protein stabilization (Fig. 3B). Nevertheless, a study on the correlation between BIRC3, p53, and Snail is currently underway. As Snail plays an important role in EMT, the role of its binding protein BIRC3 in EMT was investigated. Similar to Snail expression, BIRC3 overexpression decreased the expression of E-cadherin and increased the expression of N-cadherin, vimentin, and fibronectin (Fig. 4A). IL-1β induces the expression of BIRC3, which is involved in doxorubicin resistance in breast cancer cells. This resistance is a phenomenon related to EMT (Mendoza-Rodríguez ). BIRC3 induces EMT in hepatocellular carcinoma (Fu ). Although this study did not present a direct mechanism of how to induce EMT, our results provided some relevant insights. The knockdown of Snail expression by siSnail reduced the expressions of MMP-2 and MMP-9 (Fig. 4B). In an animal model, knockdown of Snail expression inhibited the growth and metastasis of ovarian tumours (Hojo ). Overall, Snail plays a critical role in ovarian tumour growth and metastasis via the regulation of MMP expression (Yokoyama ; Jin ). Snail-binding BIRC3 knockdown also reduced the expression of MMP2 and MMP9. (Fig. 4B). These results suggested that BIRC3 was also involved in MMP expression and likely implicated in cancer invasion. In summary, our study provided new insights into the critical role and regulatory function of Snail in cancer cell proliferation via BIRC3 and the relevant mechanism of BIRC3 in EMT via Snail. Studies on the triangle relationship between Snail, BIRC3, and p53 could yield interesting results.
  59 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

Review 2.  Epithelial-mesenchymal transition in ovarian cancer.

Authors:  Daniele Vergara; Benjamin Merlot; Jean-Philippe Lucot; Pierre Collinet; Denis Vinatier; Isabelle Fournier; Michel Salzet
Journal:  Cancer Lett       Date:  2009-10-31       Impact factor: 8.679

3.  Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein.

Authors:  T Yoneda; K Imaizumi; M Maeda; D Yui; T Manabe; T Katayama; N Sato; F Gomi; T Morihara; Y Mori; K Miyoshi; J Hitomi; S Ugawa; S Yamada; M Okabe; M Tohyama
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

4.  Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer.

Authors:  Chunyan Liu; Zhaobo Chen; Xiaoyan Ding; Yun Qiao; Bing Li
Journal:  Lab Invest       Date:  2022-01-12       Impact factor: 5.662

5.  Small C-terminal domain phosphatase enhances snail activity through dephosphorylation.

Authors:  Yadi Wu; B Mark Evers; Binhua P Zhou
Journal:  J Biol Chem       Date:  2008-11-12       Impact factor: 5.157

6.  The landscape and biological relevance of aberrant alternative splicing events in esophageal squamous cell carcinoma.

Authors:  Quanyou Wu; Yuan Zhang; Haiyin An; Wei Sun; Ruozheng Wang; Meng Liu; Kaitai Zhang
Journal:  Oncogene       Date:  2021-06-02       Impact factor: 9.867

7.  A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers.

Authors:  Brittney-Shea Herbert; Rebecca A Chanoux; Yunlong Liu; Peter H Baenziger; Chirayu P Goswami; Jeanette N McClintick; Howard J Edenberg; Robert E Pennington; Steven M Lipkin; Levy Kopelovich
Journal:  Oncotarget       Date:  2010-10

8.  Molecular profiling supports the role of epithelial-to-mesenchymal transition (EMT) in ovarian cancer metastasis.

Authors:  Loukia N Lili; Lilya V Matyunina; L Deette Walker; Stephen L Wells; Benedict B Benigno; John F McDonald
Journal:  J Ovarian Res       Date:  2013-07-10       Impact factor: 4.234

9.  The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients.

Authors:  K Blechschmidt; S Sassen; B Schmalfeldt; T Schuster; H Höfler; K-F Becker
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640

10.  Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer.

Authors:  C Dong; Y Wu; Y Wang; C Wang; T Kang; P G Rychahou; Y-I Chi; B M Evers; B P Zhou
Journal:  Oncogene       Date:  2012-05-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.